Abstract
Previously we have shown that at traumatic shock in rats the force of contraction of isolated aorta in response to angiotensin II, vasopressin, endothelin 1, or norepinephrine is decreased. On the contrary, vasoconstriction caused by serotonin is increased. A possible reason of the alterations of neuroendocrine regulation of vascular tone in shock may be a change in the expression of the receptors of these agonists in blood vessels. In the present study, using real-time PCR, we demonstrated that a day after injury the contents of mRNA encoding receptors V1A for vasopressin, ETA for endothelin 1, and AT1 for angiotensin II are not changed in aorta. There was a slight increase of the serotonin 5-HT2A receptor mRNA (36 ± 16%; p = 0.41). The level of the 5-HT2B receptor mRNA in aorta, initially low (2% of the content of the mRNA of receptors 5-HT2A), after the injury increased 15.8 ± 0.3 times (p < 0.01). However, at traumatic shock there was no contraction of aorta in response to 5-HT2B receptor agonist BW723C86, while vasodilation of the isolated aorta preconstricted with norepinephrine in response to BW723C86 was similar to that of the vessel isolated from control rats. The data obtained suggest that the observed 5-HT2B receptor overexpression is not related to the increased serotonin-induced vasoconstriction and might cause other vascular pathological changes at traumatic shock.
References
Ullmer C., Schmuck K., Kalkman H.O., Lubbert H. 1995. Expression of serotonin receptor mRNAs in blood vessels. FEBS Lett. 370, 215–221.
Watts S.W., Yang P., Banes A.K., Baez M. 2001. Activation of Erk mitogen-activated protein kinase proteins by vascular serotonin receptors. J. Cardiovasc. Pharmacol. 38, 539–551.
Kozhevnikova L.M., Mesitov M.V., Pavlova O.V., Moskovtsev A.A. 2014. The agonists of 5HT2C receptors SCH 23390 and MK212 increase the force of contraction of rat aorta in the presence of vasopressin or angiotensin II. Patologicheskaya fiziologiya i eksperimentalynaya terapiya (Rus.). 4, 17–29.
Centurion D., Ortiz M.I., Sanchez-Lopez A., DeVries P., Saxena P.R., Villalon C.M. 2001. Evidence for 5-HT(1B/1D) and 5-HT(2A) receptors mediating constriction of the canine internal carotid circulation. Br. J. Pharmacol. 132, 983–990.
McLennan P.L., Taylor D.A. 1984. Antagonism by ketanserin of 5-HT-induced vasoconstriction unmasks a 5-HT-induced vasodilation. Eur. J. Pharmacol. 104, 313–318.
Verheggen R., Meier A., Werner I., Wienekamp A., Kruschat T., Brattelid T., Levy F.O., Kaumann A. 2004. Functional 5-HT receptors in human occipital artery. Naunyn Schmiedebergs Arch. Pharmacol. 369, 391–401.
Kaumann A.J., Levy F.O. 2006. 5-hydroxytryptamine receptors in the human cardiovascular system. Pharmacol. Ther. 111, 674–706.
Nilsson T., Longmore J., Shaw D., Pantev E., Bard J.A., Branchek T., Edvinsson L. 1999. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques. Eur. J. Pharmacol. 372, 49–56.
Ellwood A.J., Curtis M.J. 1997. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries. Br. J. Pharmacol. 122, 875–884.
Terron J.A. 1996. The relaxant 5-HT receptor in the dog coronary artery smooth muscle: pharmacological resemblance to the cloned 5-ht7 receptor subtype. Br. J. Pharmacol. 118, 1421–1428.
Cushing D.J., Cohen M.L. 1993. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity. J. Pharmacol. Exp. Ther. 264, 193–200.
Chien C.C., Su M.J. 2015. 5-hydroxytryptamine has an endothelium-derived hyperpolarizing factor-like effect on coronary flow in isolated rat hearts. J. Biomed. Sci. 22, 42.
Jahnichen S., Glusa E., Pertz H.H. 2005. Evidence for 5-HT2B and 5-HT7 receptor-mediated relaxation in pulmonary arteries of weaned pigs. Naunyn Schmiedebergs Arch. Pharmacol. 371, 89–98.
Guseva D., Wirth A., Ponimaskin E. 2014. Cellular mechanisms of the 5-HT7 receptor-mediated signaling. Front. Behav. Neurosci. 8, 306.
Ishida T., Kawashima S., Hirata K., Yokoyama M. 1998. Nitric oxide is produced via 5-HT1B and 5-HT2B receptor activation in human coronary artery endothelial cells. Kobe J. Med. Sci. 44, 51–63.
Ellis E.S., Byrne C., Murphy O.E., Tilford N.S., Baxter G.S. 1995. Mediation by 5-hydroxytryptamine 2B receptors of endothelium-dependent relaxation in rat jugular vein. Br. J. Pharmacol. 114, 400–404.
Kozhevnikova L.M., Davydova A.G., Avdonin P.V. 2009. Plasma membrane depolarization and activation of receptors for endogenous vasoconstrictors as possible mechanisms of potentiation of vasoconstrictive response to serotonin in traumatic shock in rats. Izv. Akad. Nauk. Ser. Biol. (Rus.). 343–357.
Nelson P.M., Harrod J.S., Lamping K.G. 2012. 5HT(2A) and 5HT(2B) receptors contribute to serotonin- induced vascular dysfunction in diabetes. Exp. Diabetes Res. 2012, 398–406.
Banes A.K., Watts S.W. 2003. Arterial expression of 5-HT2B and 5-HT1B receptors during development of DOCA-salt hypertension. BMC Pharmacol. 3, 12.
Kozhevnikova L.M., Avdonin P.P., Sukhanova I.F., Avdonin P.V. 2008. Inversion of the response to serotonin in rats with traumatic shock. Bull. Exp. Biol. Med. 145, 298–301.
Kozhevnikova L.M., Avdonin P.V. 2006. Disturbances in hormonal regulation of vascular tone during traumatic shock. Bull. Exp. Biol. Med. 141, 574–577.
Jaffre F., Bonnin P., Callebert J., Debbabi H., Setola V., Doly S., Monassier L., Mettauer B., Blaxall B.C., Launay J.M., Maroteaux L. 2009. Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy. Circ. Res. 104, 113–123.
Mironova G.Yu., Sukhanova I.F., Zharkikh I.L., Avdonin P.P., Kozhevnikova L.M., Avdonin P.V. 2015. Vasoconstrictive effect of the agonist of serotonin 2B receptors BW723C86 in the presence of sodium orthovanadate. In: Retseptory i vnutrikletochnaya signalizatsiya. (Receptors and intracellular signaling). Eds. Zinchenko V.P., Berezhnov A.V. Pushchino: Fix-Print, vol. 1., p. 283–288.
Cottet-Maire F., Avdonin P.V., Roulet E., Buetler T.M., Mermod N., Ruegg U.T. 2001. Upregulation of vasopressin V1A receptor mRNA and protein in vascular smooth muscle cells following cyclosporin A treatment. Br. J. Pharmacol. 132, 909–917.
Murasawa S., Matsubara H., Kanasaki M., Kijima K., Maruyama K., Nio Y., Okubo N., Tsukaguchi H., Mori Y., Inada M. 1995. Characterization of glucocorticoid response element of rat angiotensin II type 1A receptor gene. Biochem. Biophys. Res. Commun. 209, 833–840.
Nebigil C.G., Choi D.S., Dierich A., Hickel P., Le Meur M., Messaddeq N., Launay J.M., Maroteaux L. 2000. Serotonin 2B receptor is required for heart development. Proc. Natl. Acad. Sci. USA. 97, 9508–9513.
Harichane Y., Dimitrova-Nakov S., Marchadier A., Collet C., Baudry A., Vidal C., Kamoun-Goldrat A., Kellermann O., Goldberg M. 2011. Enamel alterations in serotonin 2B receptor knockout mice. Eur. J. Oral. Sci. 119 (Suppl. 1), 177–184.
Callebert J., Esteve J.M., Herve P., Peoc’h K., Tournois C., Drouet L., Launay J.M., Maroteaux L. 2006. Evidence for a control of plasma serotonin levels by 5-hydroxytryptamine (2B) receptors in mice. J. Pharmacol. Exp. Ther. 317, 724–731.
Launay J.M., Herve P., Peoc’h K., Tournois C., Callebert J., Nebigil C.G., Etienne N., Drouet L., Humbert M., Simonneau G., Maroteaux L. 2002. Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat. Med. 8, 1129–1135.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © L.M. Kozhevnikova, P.P. Avdonin, I.L. Zharkikh, P.V. Avdonin, 2016, published in Biologicheskie Membrany, 2016, Vol. 33, No. 6, pp. 445–449.
Rights and permissions
About this article
Cite this article
Kozhevnikova, L.M., Avdonin, P.P., Zharkikh, I.L. et al. Traumatic shock causes elevation of the serotonin 5-HT2B receptor mRNA level in rat aorta. Biochem. Moscow Suppl. Ser. A 11, 82–86 (2017). https://doi.org/10.1134/S1990747816040140
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990747816040140